aDepartment of Hematology/Oncology, Comprehensive Cancer Center (CCC Munich), LMU University Hospital Munich, 81377 Munich, Germany bDepartment of Hematology, Oncology, and Cancer Immunology (CCM), ...
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...